Poster Session 2P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Track: SCLC, Mesothelioma, Thymoma
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2016 Published by Elsevier Inc.